The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Intellia Therapeutics Inc’s stock clocked out at $8.44, down -4.52% from its previous closing price of $8.84. In other words, the price has decreased by -$4.52 from its previous closing price. On the day, 2.62 million shares were traded.
Ratios:
To gain a deeper understanding of NTLA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.77 and its Current Ratio is at 5.77. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.22.
On March 05, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $30.
JP Morgan Downgraded its Overweight to Neutral on February 28, 2025, whereas the target price for the stock was revised from $45 to $13.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 29 ’25 when Bhanji Muna sold 265 shares for $8.50 per share. The transaction valued at 2,252 led to the insider holds 19,203 shares of the business.
Clark Eliana sold 679 shares of NTLA for $6,104 on Mar 04 ’25. The EVP, Chief Technical Officer now owns 95,369 shares after completing the transaction at $8.99 per share. On Mar 04 ’25, another insider, BASTA JAMES, who serves as the EVP, General Counsel of the company, sold 2,572 shares for $8.99 each. As a result, the insider received 23,122 and left with 111,925 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 15.09 while its Price-to-Book (P/B) ratio in mrq is 0.99.
Stock Price History:
Over the past 52 weeks, NTLA has reached a high of $28.18, while it has fallen to a 52-week low of $5.90. The 50-Day Moving Average of the stock is -1.25%, while the 200-Day Moving Average is calculated to be -43.23%.
Shares Statistics:
A total of 102.03M shares are outstanding, with a floating share count of 97.43M. Insiders hold about 5.88% of the company’s shares, while institutions hold 92.24% stake in the company.
